These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8990074

  • 1. Differential mechanisms of ovine fetal pituitary stimulation by a selective kappa-opioid agonist and by dynorphin.
    Taylor CC, WU D, Soong Y, Yee JS, Szeto HH.
    Neuroendocrinology; 1996 Dec; 64(6):419-24. PubMed ID: 8990074
    [Abstract] [Full Text] [Related]

  • 2. Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel nonopioid mechanism.
    Taylor CC, Wu D, Soong Y, Yee JS, Szeto HH.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):416-21. PubMed ID: 8996223
    [Abstract] [Full Text] [Related]

  • 3. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
    Taylor CC, Wu D, Soong Y, Yee JS, Szeto HH.
    J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
    [Abstract] [Full Text] [Related]

  • 4. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H, Maixner W.
    J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S, Kim HS, Wood PL.
    Brain Res; 1987 Dec 01; 435(1-2):220-6. PubMed ID: 2892574
    [Abstract] [Full Text] [Related]

  • 7. The role of N-methyl-D-aspartate receptors in the release of adrenocorticotropin by dynorphin A1-13.
    Szeto HH, Soong Y, Wu D.
    Neuroendocrinology; 1999 Jan 01; 69(1):28-33. PubMed ID: 9892848
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U, Wenger F, Caliezi A, Drack E, Varga L, Halter F.
    J Pharmacol Exp Ther; 1990 Mar 01; 252(3):1324-30. PubMed ID: 1969475
    [Abstract] [Full Text] [Related]

  • 13. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S, Kim HS, Wood PL.
    J Pharmacol Exp Ther; 1986 Aug 01; 238(2):429-36. PubMed ID: 3016237
    [Abstract] [Full Text] [Related]

  • 14. Role of dynorphin-containing neurons in the presynaptic inhibitory control of the acetylcholine-evoked release of dopamine in the striosomes and the matrix of the cat caudate nucleus.
    Gauchy C, Desban M, Krebs MO, Glowinski J, Kemel ML.
    Neuroscience; 1991 Aug 01; 41(2-3):449-58. PubMed ID: 1678500
    [Abstract] [Full Text] [Related]

  • 15. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
    Tiseo PJ, Geller EB, Adler MW.
    J Pharmacol Exp Ther; 1988 Aug 01; 246(2):449-53. PubMed ID: 2900324
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis.
    Oiso Y, Iwasaki Y, Kondo K, Takatsuki K, Tomita A.
    Neuroendocrinology; 1988 Dec 01; 48(6):658-62. PubMed ID: 3251164
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors.
    Utz J, Eckert R, Trautwein W.
    J Pharmacol Exp Ther; 1995 Aug 01; 274(2):627-33. PubMed ID: 7543570
    [Abstract] [Full Text] [Related]

  • 20. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 01; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.